The share holders of the company at the 34th AGM held on 23-09-2026, have approved the appointment of M/s. Divyesh J Shah & Associates, Chartered Accountants as Statutory Auditors of the Company in place of the retiring auditors M/s. Shah & Savla LLP to hold office for a term of five years from conclusion of 34th AGM till the conclusion of 39th AGM to be held in 2031. Appointed with effect from 23-09-2026.

24th September, 2026 CORPORATE RELATIONSHIP DEPARTMENT, BSE LIMITED 25th Floor, P.J. Towers, Dalal Street, Mumbai-400 001 Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 – Change in Auditors Dear Sir / Madam, Pursuant to Regulation 30 of (SEBI Listing Regulations, 2015) read with SEBI Circular No. CIR/CFD/CMD1/114/2019 dated October 18, 2019, we wish to inform that M/s Divyesh J Shah & Associates, Chartered Accountants (ICAI Firm Registration No. 118227W) was appointed as Statutory Auditors of the Company to hold the office from the conclusion of 34 (Thirty fourth) Annual General Meeting until the conclusion of 39th (Thirty Ninth) Annual General Meeting to be held for FY 2030-31. We wish to further inform that the tenure of M/s Shah & Savla LLP., as Statutory Auditor of Samrat Pharmachem Limited (“The Company”) has expired with the conclusion of 34 (Thirty fourth) Annual General Meeting for the Financial year 2025-26 which is held and concluded today i.e. 23-09-2026. Further, as the tenure of the Statutory Auditors is expired at the conclusion of the AGM of the Company and as they cannot be re-appointed as per the provisions of Companies Act, 2013, the Members at the 34th Annual General Meeting has approved the appointment of M/s Divyesh J Shah & Associates (Firm Registration No. 118227W), Chartered Accountants for a term of five (5) years to hold office from the conclusion of the 34th AGM till the conclusion of the 39th AGM of the Company to be held in year 2031. The change is on account of expiry of term/tenure of existing Statutory Auditors and appointment of new Statutory Auditors in their place in accordance with the provisions of Companies Act, 2023. The existing/outgoing Auditors have not raised any concern or issue and there is no reason other than as mentioned in their letter annexed herewith. The details of the previous auditors is provided in Annexure A as required under clause (7A) of Para A in Part A of Schedule III under Regulation 30(2) of SEBI LODR Regulations, SEBI circular CIR/CFD/CMD1/114/2019 dated October 18, 2019. Details with respect to resignation /change in Auditors of the Company as required under Regulation 30 Read with Schedule III of the Listing Regulations, SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 and are annexed herewith as Annexure-1 and Annexure -2 Kindly take this intimation in record in compliance with applicable statutory provisions. Yours Sincerely, For Samrat Pharmachem Limited Nishant Kankaria Company Secretary & Compliance Officer Place: Mumbai Date: 24th September 2026 ANNEXURE-1 Details with respect to change in Auditors of the Company as required under Regulation 30 Read with Part A Schedule III of the Listing Regulations and SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 EXPIRY OF TENURE OF M/S. SHAH & SAVLA LLP, CHARTERED ACCOUNYTANTS: SR. NO. PARTICULARS DETAILS 1. Name of the Company SAMRAT PHARMACHEM LIMITED 2. Name of the Auditor M/S. SHAH & SAVLA LLP, CHARTERED ACCOUNTANTS (FRN: 109364W / W100143). 3. Reason for Change viz., Expiry of the tenure at the conclusion of 34th appointment, AGM of the Company in accordance with the resignation, removal, death or provisions of Companies Act, 2013 otherwise 4. Effective Date of resignation Expiry of tenure with effect from conclusion of AGM dated 23-09-2026 5. Brief Profile NA 6. Disclosure of relationships NA between Directors (in case of appointment of a director) ANNEXURE II Disclosure under Sub Para A of Part A of Schedule III pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015: APPOINTMENT OF M/S. DIVYESH J SHAH & ASSOCIATES. CHARTERED ACCOUNTANTS AS STATUTORY AUDITORS: SR. NO PARTICULARS DETAILS 1 Name of the Company SAMRAT PHARMACHEM LIMITED 2 Name of the Auditor M/S. DIVYESH J SHAH & ASSOCIATES, CHARTERED ACCOUNTANTS (Firm Registration No. 118227W), 3 Reason for Change viz. Existing Auditors M/S. SHAH & SAVLA LLP, Appointment, CHARTERED ACCOUNTANTS, retired at the Conclusion Resignation, Removal, of 34TH Annual General Meeting after completing the death or otherwise term of appointment of ten years. The Shareholders of the Company at 34th AGM held on 23-09-2026, have approved the appointment of M/S DIVYESH J SHAH & ASSOCIATES, CHARTERED ACCOUNTANTS (Firm Registration No. 118227W), Chartered Accountants, as the Statutory Auditors of the Company in place of the retiring auditors, M/S. SHAH & SAVLA LLP., CHARTERED ACCOUNTANTS (Firm’s Registration No. 109364W / W100143), to hold office for a term of five years from the conclusion of the 34th Annual General Meeting (AGM) till the conclusion of 39th AGM to be held in the year 2031. 4 Date of Appointment / Appointed with effect from 23.09.2026 to hold office cessation (as applicable) from conclusion of the 34th Annual General Meeting (AGM) till the conclusion of 39th AGM to be held in the & Term of Appointment year 2031 Brief Profile M/S. DIVYESH J SHAH & ASSOCIATES, CHARTERED ACCOUNTANTS, (Firm Registration No. 118227W), Chartered audit, management consultancy, tax consultancy, accounting services, manpower management, secretarial services. The Firm is professionally managed firm since year 1998 and consists of distinguished Chartered Accountants, Corporate Financial Advisors and Tax Consultants. Disclosure in this regard has already been provided. 6 Disclosure of relationships NA between Directors (in case of appointment of a director) For Samrat Pharmachem Limited Nishant Kankaria Company Secretary & Compliance Officer Place: Mumbai Date: 24th September 2026